Y-mAbs Therapeutics
YMAB
#8047
Rank
NZ$0.36 B
Marketcap
$8.11
Share price
-2.58%
Change (1 day)
-66.49%
Change (1 year)

EPS for Y-mAbs Therapeutics (YMAB)

EPS in 2023 (TTM): -$1.52

According to Y-mAbs Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.59. In 2022 the company made an earnings per share (EPS) of -$3.90 a decrease over its 2021 EPS that were of -$2.22.

EPS history for Y-mAbs Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.52-60.98%
2022-$3.9075.81%
2021-$2.22-58.25%
2020-$5.3128.57%
2019-$4.1367.32%
2018-$2.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.90 144.94%๐Ÿ‡บ๐Ÿ‡ธ USA